Logo image of 56S1.DE

SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:56S1 - FR0013154002 - Common Stock

204.7 EUR
-1.5 (-0.73%)
Last: 1/21/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 56S1. 56S1 was compared to 22 industry peers in the Life Sciences Tools & Services industry. 56S1 has only an average score on both its financial health and profitability. 56S1 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year 56S1 was profitable.
  • 56S1 had a positive operating cash flow in the past year.
  • Each year in the past 5 years 56S1 has been profitable.
  • In the past 5 years 56S1 always reported a positive cash flow from operatings.
56S1.DE Yearly Net Income VS EBIT VS OCF VS FCF56S1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

  • 56S1 has a Return On Assets of 3.36%. This is comparable to the rest of the industry: 56S1 outperforms 40.91% of its industry peers.
  • 56S1 has a Return On Equity of 6.55%. This is comparable to the rest of the industry: 56S1 outperforms 45.45% of its industry peers.
  • 56S1 has a Return On Invested Capital (5.94%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for 56S1 is in line with the industry average of 9.34%.
  • The 3 year average ROIC (10.41%) for 56S1 is well above the current ROIC(5.94%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.36%
ROE 6.55%
ROIC 5.94%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
56S1.DE Yearly ROA, ROE, ROIC56S1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • 56S1's Profit Margin of 8.98% is in line compared to the rest of the industry. 56S1 outperforms 59.09% of its industry peers.
  • In the last couple of years the Profit Margin of 56S1 has declined.
  • With a decent Operating Margin value of 16.63%, 56S1 is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • 56S1's Operating Margin has declined in the last couple of years.
  • 56S1 has a Gross Margin (45.64%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of 56S1 has declined.
Industry RankSector Rank
OM 16.63%
PM (TTM) 8.98%
GM 45.64%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
56S1.DE Yearly Profit, Operating, Gross Margins56S1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 56S1 is creating some value.
  • The number of shares outstanding for 56S1 has been increased compared to 1 year ago.
  • The number of shares outstanding for 56S1 has been increased compared to 5 years ago.
  • Compared to 1 year ago, 56S1 has an improved debt to assets ratio.
56S1.DE Yearly Shares Outstanding56S1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
56S1.DE Yearly Total Debt VS Total Assets56S1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • 56S1 has an Altman-Z score of 4.41. This indicates that 56S1 is financially healthy and has little risk of bankruptcy at the moment.
  • 56S1 has a Altman-Z score of 4.41. This is in the better half of the industry: 56S1 outperforms 72.73% of its industry peers.
  • The Debt to FCF ratio of 56S1 is 6.84, which is on the high side as it means it would take 56S1, 6.84 years of fcf income to pay off all of its debts.
  • 56S1 has a Debt to FCF ratio (6.84) which is in line with its industry peers.
  • 56S1 has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
  • 56S1's Debt to Equity ratio of 0.50 is in line compared to the rest of the industry. 56S1 outperforms 59.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 6.84
Altman-Z 4.41
ROIC/WACC0.61
WACC9.72%
56S1.DE Yearly LT Debt VS Equity VS FCF56S1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that 56S1 should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.05, 56S1 is not doing good in the industry: 68.18% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.50 indicates that 56S1 may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.50, 56S1 is doing worse than 77.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.5
56S1.DE Yearly Current Assets VS Current Liabilites56S1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.11% over the past year.
  • Measured over the past 5 years, 56S1 shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
  • The Revenue has been growing slightly by 7.72% in the past year.
  • The Revenue has been growing by 14.05% on average over the past years. This is quite good.
EPS 1Y (TTM)35.11%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%23.68%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%7.67%

3.2 Future

  • Based on estimates for the next years, 56S1 will show a very strong growth in Earnings Per Share. The EPS will grow by 21.17% on average per year.
  • The Revenue is expected to grow by 9.86% on average over the next years. This is quite good.
EPS Next Y29.12%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
EPS Next 5Y21.17%
Revenue Next Year7.45%
Revenue Next 2Y8.04%
Revenue Next 3Y9.07%
Revenue Next 5Y9.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
56S1.DE Yearly Revenue VS Estimates56S1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
56S1.DE Yearly EPS VS Estimates56S1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 47.49 indicates a quite expensive valuation of 56S1.
  • Based on the Price/Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 72.73% of the companies are valued more cheaply.
  • 56S1 is valuated expensively when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
  • 56S1 is valuated quite expensively with a Price/Forward Earnings ratio of 38.36.
  • Based on the Price/Forward Earnings ratio, 56S1 is valued a bit more expensive than the industry average as 68.18% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of 56S1 to the average of the S&P500 Index (25.96), we can say 56S1 is valued slightly more expensively.
Industry RankSector Rank
PE 47.49
Fwd PE 38.36
56S1.DE Price Earnings VS Forward Price Earnings56S1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 56S1 indicates a slightly more expensive valuation: 56S1 is more expensive than 72.73% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of 56S1 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 53.19
EV/EBITDA 27.46
56S1.DE Per share data56S1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • 56S1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as 56S1's earnings are expected to grow with 22.85% in the coming years.
PEG (NY)1.63
PEG (5Y)11.32
EPS Next 2Y23.48%
EPS Next 3Y22.85%

4

5. Dividend

5.1 Amount

  • 56S1 has a yearly dividend return of 0.33%, which is pretty low.
  • 56S1's Dividend Yield is comparable with the industry average which is at 0.48.
  • Compared to an average S&P500 Dividend Yield of 1.82, 56S1's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.33%

5.2 History

  • The dividend of 56S1 has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
56S1.DE Yearly Dividends per share56S1.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • 56S1 pays out 25.37% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of 56S1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.37%
EPS Next 2Y23.48%
EPS Next 3Y22.85%
56S1.DE Yearly Income VS Free CF VS Dividend56S1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
56S1.DE Dividend Payout.56S1.DE Dividend Payout, showing the Payout Ratio.56S1.DE Dividend Payout.PayoutRetained Earnings

SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ

What is the ChartMill fundamental rating of SARTORIUS STEDIM BIOTECH (56S1.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to 56S1.DE.


Can you provide the valuation status for SARTORIUS STEDIM BIOTECH?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS STEDIM BIOTECH (56S1.DE). This can be considered as Overvalued.


How profitable is SARTORIUS STEDIM BIOTECH (56S1.DE) stock?

SARTORIUS STEDIM BIOTECH (56S1.DE) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for 56S1 stock?

The Price/Earnings (PE) ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 47.49 and the Price/Book (PB) ratio is 4.94.


What is the earnings growth outlook for SARTORIUS STEDIM BIOTECH?

The Earnings per Share (EPS) of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 29.12% in the next year.